EN DE
  • Paion GmbH
  • Company

    About PAION

    1. History
    2. Management
  • Insolvency Proceedings
  • Media and Investors

    At a glance

    1. General Information

    Newsroom

    1. Press Releases
    2. Ad-hoc Releases
    3. Directors' Dealings
    4. Holdings in company

    Information on shares

    1. Chart & Fact sheet
    2. Analysts
    3. Capital actions
    4. Information on CeNeS Acquisition

    Investorcenter

    1. Financial Reports
    2. Presentations
    3. Corporate calendar

    Corporate Governance

    1. Declaration on Corporate Governance
    2. Articles of Association
    3. Declaration of Conformity
    4. Code of Conduct
    5. By-Laws Supervisory Board
    6. Compensation Management Board and Supervisory Board

    Annual general meeting

    2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
  • Contact

    Germany

    UK

    Netherlands

Here you will find information on PAION AG i.L. relevant to stock corporation and stock exchange law.

The operating business of PAION AG i.L. and PAION Deutschland GmbH i.L. has been transferred to PAION Pharma GmbH as part of the insolvency proceedings.

You can reach PAION Pharma GmbH at www.paionpharma.com

  • Media and Investors
  •  »  Newsroom
  •  »  Press Releases
  •  »  2023
  • 12/22/2023

    Sale of the business operations

    • Read more

  • 11/22/2023

    PAION AG CHANGES FROM PRIME STANDARD TO GENERAL STANDARD

    • Read more

  • 11/21/2023

    PAION AG SIGNS STRATEGIC COOPERATION AGREEMENT WITH YICHANG HUMANWELL

    • Read more

  • 10/31/2023

    PAION AG HAS FILED FOR THE OPENING OF INSOLVENCY PROCEEDINGS - PRELIMINARY INSOLVENCY ADMINISTRATOR APPOINTED

    • Read more

  • 10/20/2023

    PAION AG to issue approximately 4.8 million shares at EUR 1.90 per share in capital increase with subscription rights

    • Read more

  • 10/13/2023

    Press release: PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million

    • Read more

  • 09/28/2023

    PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE MUNDIPHARMA IN JAPAN

    • Read more

  • 08/31/2023

    PAION receives UK MHRA approval of Byfavo® (remimazolam) for the induction and maintenance of general anesthesia in adults

    • Read more

  • 08/30/2023

    PAION AG reports financial results for the First Half-Year 2023

    • Read more

  • 08/22/2023

    PAION launches Byfavo® (remimazolam) in the first European country for General Anesthesia

    • Read more

  • 07/17/2023

    PAION AG: HANA PHARM RECEIVES MARKET APPROVAL FOR BYFAVO IN GENERAL ANESTHESIA IN THE PHILIPPINES

    • Read more

  • 07/12/2023

     PAION AG SUCCESSFULLY HOLDS ITS ANNUAL GENERAL MEETING 2023

    • Read more

  • 05/25/2023

    ​​​​​​​PAION IS HOSTING A SPONSORED BYFAVO® SYMPOSIUM AT  EUROANAESTHESIA 2023 IN GLASGOW

    • Read more

  • 05/17/2023

    PAION AG publishes GROUP QUARTERLY STATEMENT for the first quarter of 2023

    • Read more

  • 04/25/2023

    POSTPONEMENT OF PUBLICATION OF THE ANNUAL AND CONSOLIDATED FINANCIAL STATEMENTS 2022

    • Read more

  • 03/31/2023

    PAION AG implements resolved capital reduction

    • Read more

  • 03/30/2023

    PAION AG reports on fiscal year 2022

    • Read more

  • 03/16/2023

    PAION IS HOSTING A SPONSORED ANGIOTENSIN II SYMPOSIUM AT ISICEM IN BRUSSELS

    • Read more

  • 01/25/2023

    PAION AG: Extraordinary General Meeting approves capital reductions and creates scope for further corporate financing

    • Read more

  • 01/19/2023

    ​​​​​​​PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE CRISTÁLIA IN BRASIL

    • Read more

  • copyright © PAION AG I all rights reserved
  • Imprint
  • Privacy Statement
  • General Terms and Conditions
Paion

Heussstraße 25 | 52078 Aachen | Deutschland

Tel.: +49 241 4453-0 | Fax.: +49 241 4453-100 | e-mail: info@paion.com

Company
  1. About PAION +
    1. History
    2. Management
Insolvency Proceedings
Media and Investors
  1. At a glance +
    1. General Information
  2. Newsroom +
    1. Press Releases
    2. Ad-hoc Releases
    3. Directors' Dealings
    4. Holdings in company
  3. Information on shares +
    1. Chart & Fact sheet
    2. Analysts
    3. Capital actions
    4. Information on CeNeS Acquisition
  4. Investorcenter +
    1. Financial Reports
    2. Presentations
    3. Corporate calendar
  5. Corporate Governance +
    1. Declaration on Corporate Governance
    2. Articles of Association
    3. Declaration of Conformity
    4. Code of Conduct
    5. By-Laws Supervisory Board
    6. Compensation Management Board and Supervisory Board
  6. Annual general meeting +
    1. 2023
    2. 2022
    3. 2021
    4. 2020
    5. 2019
    6. 2018
    7. 2017
    8. 2016
    9. 2015
    10. 2014
    11. 2013
    12. 2012
    13. 2011
Contact
  1. Germany
  2. UK
  3. Netherlands
Cookie Settings

This website uses cookies.

Some of them are essential and required for running the website. Others improve your user experience and may be activated or deactivated at your discretion.

Accept all Save
Privacy Statement Imprint